T Cell and Natural Killer Cell Membrane-Camouflaged Nanoparticles for Cancer and Viral Therapies DOI Creative Commons

Fatma Ozsoy,

Mahir M. Sharif, Nasrullah Jan

и другие.

ACS Applied Bio Materials, Год журнала: 2024, Номер 7(5), С. 2637 - 2659

Опубликована: Апрель 30, 2024

Extensive research has been conducted on the application of nanoparticles in treatment cancer and infectious diseases. Due to their exceptional characteristics flexible structure, they are classified as highly efficient drug delivery systems, ensuring both safety targeted delivery. Nevertheless, still encounter obstacles, such biological instability, absence selectivity, recognition unfamiliar elements, quick elimination, which restrict remedial capacity. To surmount these drawbacks, biomimetic nanotechnology developed that utilizes T cell natural killer (NK) membrane-encased sophisticated methods administering drugs. These can extend duration circulation avoid immune system clearance. During membrane extraction coating procedure, surface proteins immunological cells transferred nanoparticles. Such present confer several benefits nanoparticles, including prolonged circulation, enhanced targeting, controlled release, specific cellular contact, reduced vivo toxicity. This review focuses nanosystems derived from membranes NK comprehensive manufacture, applications viral infections. Furthermore, potential applications, prospects, existing challenges medical implementation highlighted.

Язык: Английский

Boosting ferroptosis by intervention of redox balance and synergetic with photothermal/photodynamic therapy for suppression of pancreatic cancer DOI
Yixun Jin, Jia Huang, Yuming Tang

и другие.

Chemical Engineering Journal, Год журнала: 2024, Номер 497, С. 154569 - 154569

Опубликована: Авг. 5, 2024

Язык: Английский

Процитировано

4

Carbon nanomaterials: a promising avenue in colorectal cancer treatment DOI
Marzieh Ramezani Farani,

Mandana Lak,

William C. Cho

и другие.

Carbon letters, Год журнала: 2024, Номер unknown

Опубликована: Сен. 23, 2024

Язык: Английский

Процитировано

4

Dysregulation of autophagy in gastric carcinoma: Pathways to tumor progression and resistance to therapy DOI
Wen Wen, Yavuz Nuri Ertaş, Ahmet Erdem

и другие.

Cancer Letters, Год журнала: 2024, Номер 591, С. 216857 - 216857

Опубликована: Апрель 5, 2024

Язык: Английский

Процитировано

3

Nanomaterials in crossroad of autophagy control in human cancers: Amplification of cell death mechanisms DOI
Gang Zhao, Yutao Wang, Zhongru Fan

и другие.

Cancer Letters, Год журнала: 2024, Номер 591, С. 216860 - 216860

Опубликована: Апрель 6, 2024

Язык: Английский

Процитировано

3

T Cell and Natural Killer Cell Membrane-Camouflaged Nanoparticles for Cancer and Viral Therapies DOI Creative Commons

Fatma Ozsoy,

Mahir M. Sharif, Nasrullah Jan

и другие.

ACS Applied Bio Materials, Год журнала: 2024, Номер 7(5), С. 2637 - 2659

Опубликована: Апрель 30, 2024

Extensive research has been conducted on the application of nanoparticles in treatment cancer and infectious diseases. Due to their exceptional characteristics flexible structure, they are classified as highly efficient drug delivery systems, ensuring both safety targeted delivery. Nevertheless, still encounter obstacles, such biological instability, absence selectivity, recognition unfamiliar elements, quick elimination, which restrict remedial capacity. To surmount these drawbacks, biomimetic nanotechnology developed that utilizes T cell natural killer (NK) membrane-encased sophisticated methods administering drugs. These can extend duration circulation avoid immune system clearance. During membrane extraction coating procedure, surface proteins immunological cells transferred nanoparticles. Such present confer several benefits nanoparticles, including prolonged circulation, enhanced targeting, controlled release, specific cellular contact, reduced vivo toxicity. This review focuses nanosystems derived from membranes NK comprehensive manufacture, applications viral infections. Furthermore, potential applications, prospects, existing challenges medical implementation highlighted.

Язык: Английский

Процитировано

3